Literature DB >> 17352266

Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer.

Hidenori Akaike1, Koji Kono, Hidemitsu Sugai, Akihiro Takahashi, Kousaku Mimura, Yoshihiko Kawaguchi, Hideki Fujii.   

Abstract

The intranuclear architectural protein termed high mobility group box chromosomal protein 1 (HMGB-1) has recently been identified as a potent proinflammatory mediator. The release of HMGB-1 results in the activation of macrophages and leads to an inflammatory response. In the tumor microenvironment, it is well known that there are local inflammatory reactions and the degree of inflammatory cell infiltration inside a tumor is correlated to the prognosis of the disease. In the present study, the expression of HMGB-1 in gastric cancer cells was evaluated in relation to the clinicopathological findings (n = 76), and its expression was analyzed in comparison to immune reactive cells in gastric cancer. The expression of HMGB-1 in gastric cancer cells with the intestinal type (90.7 positive cells per 200 cancer cells +/- 37.9, n = 40) was significantly increased compared to that in the diffuse type (56.8 +/- 32.7, n = 36) (p < 0.01). Secondly, HMGB-1 expression in gastric cancer cells was positively correlated with the degree of macrophage infiltration inside the tumor microenvironment (r = 0.869, p < 0.01). Thirdly, the prognosis of the low HMGB-1 group (n = 41) was significantly poorer than that of the high HMGB-1 group (n = 35, p < 0.05), although the HMGB-1 expression in cancer cells was not an independent prognostic factor. HMGB-1 expression may be one of the key factors regulating inflammatory reactions within the tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17352266

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  29 in total

1.  High-mobility group box 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.

Authors:  Wei Jiang; Zhiming Wang; Xinying Li; Xuegong Fan; Yankun Duan
Journal:  Pathol Oncol Res       Date:  2011-09-07       Impact factor: 3.201

2.  HMGB1 promotes lymphangiogenesis of human lymphatic endothelial cells in vitro.

Authors:  Yuanyuan Qiu; Ying Chen; Xin Fu; Lei Zhang; Jing Tian; Quan Hao
Journal:  Med Oncol       Date:  2010-12-22       Impact factor: 3.064

3.  Downregulation of high mobility group protein box-1 resensitizes ovarian cancer cells to carboplatin.

Authors:  Wen Shu
Journal:  Oncol Lett       Date:  2018-07-30       Impact factor: 2.967

4.  Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells.

Authors:  Jing Zhang; Cang Liu; Ruiguang Hou
Journal:  Chin J Cancer Res       Date:  2014-12       Impact factor: 5.087

5.  Reduced high-mobility group box 1 expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cell line HCCLM3.

Authors:  Wei Jiang; Zhiming Wang; Xinying Li; Jindong Li; Yun Huang; Xuegong Fan; Yankun Duan
Journal:  Dig Dis Sci       Date:  2011-10-26       Impact factor: 3.199

Review 6.  HMGB1 in hormone-related cancer: a potential therapeutic target.

Authors:  Madhuwanti Srinivasan; Souresh Banerjee; Allison Palmer; Guoxing Zheng; Aoshuang Chen; Maarten C Bosland; André Kajdacsy-Balla; Ramaswamy Kalyanasundaram; Gnanasekar Munirathinam
Journal:  Horm Cancer       Date:  2014-04-10       Impact factor: 3.869

7.  A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma.

Authors:  Fatima Solange Pasini; Bruno Zilberstein; Igor Snitcovsky; Rosimeire Aparecida Roela; Flavia R Rotea Mangone; Ulysses Ribeiro; Suely Nonogaki; Glauber Costa Brito; Giovanna D Callegari; Ivan Cecconello; Venancio Avancini Ferreira Alves; José Eluf-Neto; Roger Chammas; Miriam Hatsue Honda Federico
Journal:  J Gastroenterol       Date:  2013-11-12       Impact factor: 7.527

Review 8.  Potential role of High mobility group box 1 in hepatocellular carcinoma.

Authors:  Rong-Rong Zhou; Xu-Yuan Kuang; Yan Huang; Ning Li; Ming-Xiang Zou; Dao-Lin Tang; Xue-Gong Fan
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

9.  Analysis of the expression protein profiles of lung squamous carcinoma cell using shot-gun proteomics strategy.

Authors:  Yandong Nan; Shuanying Yang; Yingxuan Tian; Wei Zhang; Bin Zhou; Lina Bu; Shufen Huo
Journal:  Med Oncol       Date:  2008-11-06       Impact factor: 3.064

10.  Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer.

Authors:  Chu-Biao Zhao; Ji-Ming Bao; Yong-Jie Lu; Tong Zhao; Xin-Hua Zhou; Da-Yong Zheng; Shan-Chao Zhao
Journal:  Am J Cancer Res       Date:  2014-07-16       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.